Prologis, Inc.

PLD · CIK 0001045609reit template: specialized rows coming in Phase 1

17 fiscal years · 60 SEC filings · every number carries its receipt

Revenue (FY)

$8.79B7.2%

FY2025

Net income (FY)

$3.33B10.8%

FY2025

Diluted EPS (FY)

$3.5611.2%

FY2025

The story, charted

The shape of the business

FY2016–FY2025 · hover any year for its receipt

Revenue & net incomeRevenueNet income

revenue 3.5× since FY2016 · net margin 47.8% → 37.9%

MarginsNet marginFCF margin

FY2025: net 37.9% of revenue

Cash engineOperating cash flowFree cash flow

Returns on capitalReturn on equityReturn on assets

return on equity -17% (FY2010) → 6% (FY2025) · on assets 3.4%

Balance sheetLiabilitiesEquity

FY2025: $98.72B assets · $40.97B liabilities · $53.19B equity

The receipts

Financial statements

Annual Quarterly (as reported)

USD in millions except per-share and share counts. Every value links to the filing it came from — hover for the us-gaap tag, click for the 10-K/10-Q on sec.gov.

USD millions	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022
Revenue	2,298	2,214	2,184	2,140	2,036	2,008	1,957	1,915	2,451	1,769	1,751	1,252
Net income	982	764	571	593	1,006	861	586	748	1,216	465	1,015	611
Diluted EPS	1.05	0.82	0.61	0.63	1.08	0.92	0.63	0.80	1.31	0.50	1.36	0.82
Diluted shares	958	957	956	956	954	953	954	952	952	952	766	766
Operating cash flow	1,288	—	—	1,161	—	—	1,055	—	—	1,114	—	—
Cash & equivalents	861	1,186	1,066	671	781	598	501	741	531	523	636	438
Total assets	98,133	98,341	97,717	95,993	95,905	93,537	93,310	91,949	92,392	88,521	60,946	59,764
Total liabilities	40,185	41,129	40,410	37,918	38,241	35,614	35,513	33,689	34,314	31,056	21,339	20,890
Shareholders' equity	53,503	52,636	52,729	53,467	53,072	53,345	53,191	53,636	53,466	52,835	35,293	34,576

Figures as reported in SEC filings, normalized by stonks with the tag mapping shown on hover; missing tags render as “—”, never as zero. Free cash flow is derived (operating cash flow − capex) with both parents recorded in its lineage. Quarterly view shows as-reported 10-Q periods; Q4 synthesis ships in Phase 1. See methodology.